Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-08-23

Clinical Trial Update: Pharmacokinetics, Efficacy, Tolerability and Safety of Different Budesonide Oral Gel Doses in Adults' Subjects of Both Genders With Eosinophilic Esophagitis (EoE) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pharmacokinetics, efficacy, tolerability, and safety of different budesonide oral gel doses in adults with eosinophilic esophagitis was…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • budesonide oral gel (budesonide)

Snippet

Sponsor: Bazell Pharma AG | Conditions: Eosinophilic Esophagitis | Phase 2 | Status: WITHDRAWN